Lucid Diagnostics Inc (LUCD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -21,617 | -10,612 | -52,666 | -41,836 | -27,628 |
| Depreciation Amortization | 730 | 501 | 2,499 | 1,870 | 1,245 |
| Accounts receivable | -115 | -4 | -28 | -4 | -18 |
| Accounts payable and accrued liabilities | -243 | -176 | 89 | -62 | -419 |
| Other Working Capital | -847 | -539 | 1,295 | 550 | -364 |
| Other Operating Activity | -2,002 | -1,782 | 15,994 | 16,644 | 13,127 |
| Operating Cash Flow | $-24,094 | $-12,612 | $-32,817 | $-22,838 | $-14,057 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -37 | -37 | -221 | -46 | -32 |
| Investing Cash Flow | $-37 | $-37 | $-221 | $-46 | $-32 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 10,000 | 10,000 | 10,000 |
| Common Stock Issued | 357 | 357 | 835 | 835 | 560 |
| Other Financing Activity | 29,798 | 18,165 | 18,625 | 13,625 | 13,625 |
| Financing Cash Flow | $30,155 | $18,522 | $29,460 | $24,460 | $24,185 |
| Beginning Cash Position | 18,896 | 18,896 | 22,474 | 22,474 | 22,474 |
| End Cash Position | 24,920 | 24,769 | 18,896 | 24,050 | 32,570 |
| Net Cash Flow | $6,024 | $5,873 | $-3,578 | $1,576 | $10,096 |
| Free Cash Flow | |||||
| Operating Cash Flow | -24,094 | -12,612 | -32,817 | -22,838 | -14,057 |
| Capital Expenditure | -37 | -37 | -221 | -46 | -32 |
| Free Cash Flow | -24,131 | -12,649 | -33,038 | -22,884 | -14,089 |